Tikun Olam-Cannbit Pharmaceuticals Ltd Stock TEL AVIV STOCK EXCHANGE
Equities
TKUN
IL0010843675
Pharmaceuticals
Sales 2022 | 49.3 185.83 | Sales 2023 | 44.23 166.72 | Capitalization | 25.49M 96.08M |
---|---|---|---|---|---|
Net income 2022 | -48M -181M | Net income 2023 | -88M -332M | EV / Sales 2022 | 1,234,605 x |
Net Debt 2022 | 17.5M 65.97M | Net Debt 2023 | 13.42M 50.58M | EV / Sales 2023 | 879,698 x |
P/E ratio 2022 |
-0.97
x | P/E ratio 2023 |
-0.22
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 61.97% |
Managers | Title | Age | Since |
---|---|---|---|
Ifat Kariv
CEO | Chief Executive Officer | 50 | - |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Revital Aviram
BRD | Director/Board Member | 66 | 15-02-14 |
Erez Navon
BRD | Director/Board Member | 50 | - |
Ifat Kariv
CEO | Chief Executive Officer | 50 | - |
1st Jan change | Capi. | |
---|---|---|
+20.15% | 3.56B | |
+112.55% | 2.02B | |
+80.95% | 59.43M | |
+265.38% | 54.09M |